Showing results (131-140 of 472) with videos related to
Sort By:
Pageof 48
Therapeutic Advances in Cardiovascular Disease|December 22, 2017
Perspective: interesterified triglycerides, the recent increase in deaths from heart disease, and elevated blood viscosityGregory D Sloop, Joseph J Weidman, John A St CyrTherapeutic Advances in Cardiovascular Disease|December 12, 2019
Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical useDavide Capodanno, Rocco P Milluzzo, Dominick J AngiolilloTherapeutic Advances in Cardiovascular Disease|March 13, 2018
Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of strokeJustin M Cloutier, Clarence Khoo, Brett Hiebert, et al.Therapeutic Advances in Cardiovascular Disease|February 20, 2018
Pyogenic infection of the hip joint as a complication of a femoral artery vascular access for percutaneous coronary interventionJaroslaw Ucieklak, Robert Michał ProczkaTherapeutic Advances in Cardiovascular Disease|February 18, 2014
No evidence of nitrate tolerance caused by nebivololKurt Stoschitzky, Gergana Stoschitzky, Burkert Pieske, et al.Therapeutic Advances in Cardiovascular Disease|February 5, 2014
Efficacy and safety of olmesartan/amlodipine/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn studyHenry A PunziTherapeutic Advances in Cardiovascular Disease|June 6, 2017
Taurine supplementation has anti-atherogenic and anti-inflammatory effects before and after incremental exercise in heart failureMehdi Ahmadian, Valiollah Dabidi Roshan, Elaheh Aslani, et al.Therapeutic Advances in Cardiovascular Disease|March 5, 2010
The role of endothelial cells and their progenitors in intimal hyperplasiaS D Patel, M Waltham, A Wadoodi, et al.Therapeutic Advances in Cardiovascular Disease|March 5, 2010
Beta-blockers and risk of all-cause mortality in non-cardiac surgeryFabio Angeli, Paolo Verdecchia, Ganesan Karthikeyan, et al.Therapeutic Advances in Cardiovascular Disease|June 20, 2018
Evaluation of the impact of body mass index on warfarin requirements in hospitalized patientsKatie B Tellor, Steffany N Nguyen, Amanda C Bultas, et al.Pageof 48